Your browser doesn't support javascript.
Safety of Nirsevimab for RSV in Infants with Heart or Lung Disease or Prematurity.
Domachowske, Joseph; Madhi, Shabir A; Simões, Eric A F; Atanasova, Victoria; Cabañas, Fernando; Furuno, Kenji; Garcia-Garcia, Maria L; Grantina, Ineta; Nguyen, Kim A; Brooks, Dennis; Chang, Yue; Leach, Amanda; Takas, Therese; Yuan, Yuan; Griffin, M Pamela; Mankad, Vaishali S; Villafana, Tonya.
  • Domachowske J; State University of New York Upstate Medical University, Syracuse, NY.
  • Madhi SA; University of the Witwatersrand, Johannesburg, South Africa.
  • Simões EAF; Children's Hospital Colorado, Aurora, CO.
  • Atanasova V; Dr. Georgi Stranski University Hospital, Pleven, Bulgaria.
  • Cabañas F; Quironsalud Madrid University Hospital, Madrid, Spain.
  • Furuno K; Fukuoka Children's Hospital, Fukuoka, Japan.
  • Garcia-Garcia ML; University Hospital Severo Ochoa, Madrid, Spain.
  • Grantina I; Bernu Kliniska Universitates Slimnica, Riga, Latvia.
  • Nguyen KA; Hospices Civils de Lyon, Lyon, France.
  • Brooks D; AstraZeneca, Gaithersburg, MD.
  • Chang Y; AstraZeneca, Gaithersburg, MD.
  • Leach A; AstraZeneca, Gaithersburg, MD.
  • Takas T; AstraZeneca, Gaithersburg, MD.
  • Yuan Y; AstraZeneca, Gaithersburg, MD.
  • Griffin MP; AstraZeneca, Gaithersburg, MD.
  • Mankad VS; AstraZeneca, Durham, NC.
  • Villafana T; AstraZeneca, Gaithersburg, MD tonya.villafana@astrazeneca.com.
N Engl J Med ; 386(9): 892-894, 2022 03 03.
Article in English | MEDLINE | ID: covidwho-1721731

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Infant, Premature / Respiratory Syncytial Virus Infections / Antibodies, Monoclonal, Humanized / Infant, Premature, Diseases Type of study: Randomized controlled trials Topics: Long Covid Limits: Humans / Infant / Infant, Newborn Language: English Journal: N Engl J Med Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Infant, Premature / Respiratory Syncytial Virus Infections / Antibodies, Monoclonal, Humanized / Infant, Premature, Diseases Type of study: Randomized controlled trials Topics: Long Covid Limits: Humans / Infant / Infant, Newborn Language: English Journal: N Engl J Med Year: 2022 Document Type: Article